메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

전체기사

Libevitug Approved in China as First-in-Class Treatment for Hepatitis D

BEIJING, Jan. 27, 2026 -- Huahui Health announced that China National Medical Products Administration (NMPA) has granted conditional approval to its Libevitug injection for the treatment of chronic hepatitis D virus infection in adults with or without compensated cirrhosis. Libevitug is a human monoclonal antibody targeting the PreS1 domain of the large envelope protein of hepatitis B virus (HBV) and hepatitis D virus (HDV), thereby blocking viral entry into hepatocytes. As a groundbreaking achievement in viral hepatitis therapeutics, Libevitug is a first-in-class antibody therapeutic for vir
- 김갑성 기자
- 2026-01-27 16:18
Libevitug Approved in China as First-in-Class Hepatitis D Treatment

BEIJING, Jan. 27, 2026 -- Huahui Health announced that China's National Medical Products Administration (NMPA) has granted conditional approval to its Libevitug injection for chronic hepatitis D virus (HDV) infection in adults with or without compensated cirrhosis. Libevitug is a human monoclonal antibody targeting the PreS1 domain of hepatitis B virus (HBV) and HDV envelope proteins, blocking viral entry into hepatocytes. As a groundbreaking advance in viral hepatitis care, it is China's first approved HDV therapy and a first-in-class antibody for viral hepatitis, addressing a critical clini
- 김갑성 기자
- 2026-01-27 16:15
Servier delivers solid performance in 2024/25 and confirms its forecasts for 2030

Servier reported Group revenues of €6.9 billion for 2024/25, up 16.2% from 2023/24. Growth over the financial year was driven by increased sales in oncology, particularly in the United States. Several partnership agreements in oncology and neurology strengthen the Group's R&D portfolio in rare diseases. Achieving 2025 targets reflects successful transformation that began in 2015 and underpins the Group's ambitions for 2030. SURESNES, France, Jan. 27, 2026 -- Servier, an independent international pharmaceutical group governed by a foundation, published its financi
- 김갑성 기자
- 2026-01-27 16:00
CSOP Huatai-PineBridge CSI A500 ETF Will List on Hong Kong Stock Exchange Tomorrow

HONG KONG, Jan. 27, 2026 -- Hong Kong's first CSI A500 Index ETF— CSOP Huatai-PineBridge CSI A500 ETF (Stock Code: 3101.HK), will list on Hong Kong Stock Exchange (HKEX) on January 28, 2026. The listing price for 3101.HK is approximately HKD 7.9 per share, the trading lot size is 100 shares, and the annual management fee is 0.99%. The listing of CSOP Huatai-PineBridge CSI A500 ETF on HKEX marks the continued opening-up of China's financial markets and an important step in the internationalization of Chinese assets. 3101.HK is a feeder fund that, to achieve its investmen
- 황정호 기자
- 2026-01-27 16:00
The Sanya EDITION Redefines Contemporary Chinese New Year Escapes for the Year of the Horse 2026

SANYA, China, Jan. 27, 2026 -- Set along the pristine coastline of Hainan, The Sanya EDITION draws inspiration from the vast ocean that surrounds it, striking a refined balance between natural serenity and contemporary energy. From the moment of arrival, the experience is designed to impress: guests pass through lush tropical gardens before arriving at a semi-open lobby, where layered teak wood pavillions, reflective water features and bamboo groves frame uninterrupted views of the South China Sea. A gentle sea breeze carries the signature scent of Le Labo black tea, while impeccably styled h
- 김장윤(JASON KIM) 기자
- 2026-01-27 15:49
3Shape appoints Rasmus Hannemann as Senior Vice President, Portfolio & Product Strategy

COPENHAGEN, Denmark, Jan. 27, 2026 -- 3Shape today announced the appointment of Rasmus Hannemann as Senior Vice President, Portfolio & Product Strategy, effective 9 March. Rasmus will step into the Senior Leadership Team and will report directly to CEO Jacob Paulsen. Rasmus joins 3Shape from Coloplast, where he spent more than 20 years in senior leadership roles spanning strategy, product management, marketing, and global business leadership. Most recently, he served as Vice President, Group Development & Strategy, with responsibility for corporate strategy, M&A, and post-m
- 김갑성 기자
- 2026-01-27 15:45
NetDragon and Volcengine Establish Partnership to Build a New AIGC Ecosystem

HONG KONG, Jan. 27, 2026 -- NetDragon Websoft Holdings Limited ("NetDragon" or "the Company"; Hong Kong Stock Code: 777), a global leader in building internet communities, is pleased to announce that it has entered into an AI ecosystem and innovation cooperation framework agreement with Volcengine, the cloud and AI services platform of ByteDance. Through this partnership, the two parties will collaborate across technology, resources and ecosystem development to scale the production of next-generation AIGC-powered educational resources and foster a globally co-creat
- 김장윤(JASON KIM) 기자
- 2026-01-27 15:41
Getinge Q4 and Full-Year Report 2025: Organic growth and solid cash flow to end the year

GOTHENBURG, Sweden, Jan. 27, 2026 -- "We succeeded in growing organically, delivering a record-breaking fourth quarter and organic growth at the upper end of our forecast, 4.9% for the full year," says Mattias Perjos, President & CEO at Getinge. Higher demand for consumables for ECLS-therapy in the quarter and in Acute Care Therapies contributed to Getinge's performance. Sales were also strong in Transplant Care and ventilators. Surgical Workflows continued to strengthen its market-leading position in operating tables and enters 2026 with robust order bookings. In general
- 김갑성 기자
- 2026-01-27 15:23
Davos Spotlight | EVYD, Ministry of Health Brunei Darussalam and Novartis Foundation Launch National AI-Powered Cardiovascular Disease Prevention Initiative

DAVOS, Switzerland, Jan. 27, 2026 -- At the 2026 World Economic Forum Annual Meeting in Davos, Dr. Giovanni Caforio, Chairman of the Board of Directors of Novartis, announced a major new partnership: the Novartis Foundation, the Ministry of Health of Brunei Darussalam, and EVYD Technology will jointly implement an AI- and data-enabled national cardiovascular disease prevention initiative under the global program: CARDIO4Cities. Built on Brunei's national health platform, the program aims to harness population-scale data and artificial intelligence to enable early identification of high
- 김갑성 기자
- 2026-01-27 14:37
Universal Studios Japan to Deliver Immersive Pokemon Experiences for Fans

OSAKA, Japan, Jan. 27, 2026 -- On January 27, Universal Studios Japan, operated by USJ LLC, and The Pokemon Company announced their plan to offer more innovative, immersive, and world-class Pokemon experiences. The project is part of Universal Studios Japan's ongoing effort to enhance its offerings and bring fan-first, trip-driving characters to the park. Image: https://cdn.kyodonewsprwire.jp/prwfile/release/M108172/202601212812/_prw_PI3fl_SEE5eL7J.jpg Universal Studios Japan is proud to build on its prior success and bring to life the world of Pokemon in new and enriching ways
- 김장윤(JASON KIM) 기자
- 2026-01-27 14:00

이전

91 92 93 94 95 96 97 98 99 100

많이 본 기사

최근기사

2026-03-03_TUE

2026-03-02_MON

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 03월 03일 03시 40분